Emmanuel A Ojo-Amaize
Immune Modulation, Inc., (IMI), P.O. Box 998 Bloomington, CA 92316-0998,
Tanzania
Short Review
Short Review of Current Research on the Development of Hypoestoxide as a
Therapeutic Agent for Parkinsons Disease
Author(s): Emmanuel A Ojo-Amaize and Howard B CottamEmmanuel A Ojo-Amaize and Howard B Cottam
Parkinson’s disease (PD) is a common neurodegenerative disorder belonging to a heterogeneous group of disorders with α-synuclein pathology and PD dementia. Hypoestoxide is being developed to combat microgliosis, astrogliosis, loss of dopaminergic neurons, motor behavioral deficits and α-synuclein pathology in PD... View More»
